We are live on ! Find out more
FA

Forefront Analytics Portfolio holdings

AUM $110M
1-Year Est. Return 18.54%
This Fund
S&P 500
This Quarter Est. Return
-4.23%
1 Year Est. Return
+18.54%
3 Year Est. Return
+33.55%
5 Year Est. Return
+24.76%
10 Year Est. Return
AUM
$215M
AUM Growth
+$2.98M
Cap. Flow
+$12.2M
Cap. Flow %
5.69%
Top 10 Hldgs %
53.42%
Holding
71
New
4
Increased
35
Reduced
25
Closed
7
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EW icon
51
Edwards Lifesciences
EW
$49.4B
$239K 0.11%
3,226
+84
+3% +$5.88K
RPAR icon
52
RPAR Risk Parity ETF
RPAR
$574M
$219K 0.1%
11,701
-4,460
-28% -$87.8K
TMO icon
53
Thermo Fisher Scientific
TMO
$198B
$215K 0.1%
413
-17
-4% -$9.35K
BSCU icon
54
Invesco BulletShares 2030 Corporate Bond ETF
BSCU
$2.63B
$173K 0.08%
10,596
-25,402
-71% -$421K
ZURA icon
55
Zura Bio
ZURA
$518M
$134K 0.06%
53,734
+22,924
+74% +$81.7K
MREO
56
Mereo BioPharma
MREO
$49.5M
$122K 0.06%
34,753
+953
+3% +$3.74K
IMTX icon
57
Immatics
IMTX
$1.31B
$113K 0.05%
15,911
+4,731
+42% +$40.7K
COGT icon
58
Cogent Biosciences
COGT
$6.68B
$107K 0.05%
13,760
+3,739
+37% +$37.3K
KRON
59
DELISTED
Kronos Bio
KRON
$88.5K 0.04%
93,190
+2,192
+2% +$2.07K
ITOS
60
DELISTED
iTeos Therapeutics
ITOS
$84.9K 0.04%
+11,061
New +$95K
ANNX icon
61
Annexon
ANNX
$950M
$84.3K 0.04%
16,433
+5,950
+57% +$36.6K
NKTX icon
62
Nkarta
NKTX
$186M
$74.8K 0.03%
30,046
+12,400
+70% +$38.3K
GERN icon
63
Geron
GERN
$924M
$67.3K 0.03%
19,023
+532
+3% +$2.13K
CTMX icon
64
CytomX Therapeutics
CTMX
$788M
$66.2K 0.03%
64,259
+4,499
+8% +$4.84K
ESGG icon
65
FlexShares STOXX Global ESG Select Index Fund
ESGG
$109M
-53,144
Closed -$9.17M
PDP icon
66
Invesco Dorsey Wright Momentum ETF
PDP
$1.47B
-16,690
Closed -$1.72M
REET icon
67
iShares Global REIT ETF
REET
$5.05B
-13,261
Closed -$354K
SCHA icon
68
Schwab U.S Small- Cap ETF
SCHA
$22.7B
-18,024
Closed -$464K
TLT icon
69
iShares 20+ Year Treasury Bond ETF
TLT
$42.1B
-5,035
Closed -$494K
VWOB icon
70
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.21B
-5,776
Closed -$383K
PSTX
71
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
-27,855
Closed -$79.7K

Similar funds

Forefront Analytics's Q4 2024 Portfolio in Review

As of Q4 2024, Forefront Analytics held 71 positions worth $215M, up 1.4% from $212M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Forefront Analytics deployed $12.2M of net new capital in Q4 2024, opening 4 new positions and adding to 35 existing holdings. Its largest new stake was iShares Core Conservative Allocation ETF: 347,277 shares worth $13M.

By sector, the portfolio is most concentrated in Healthcare at 1.6% of assets, down from 1.7% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $11.3M trimmed.

  • Forefront Analytics's largest Q4 2024 buy was iShares Core Conservative Allocation ETF: 347,277 shares worth $13M.
  • Forefront Analytics added most to iShares JPMorgan USD Emerging Markets Bond ETF in Q4 2024, an estimated $7.27M increase.
  • Forefront Analytics's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $11.3M.
  • Forefront Analytics fully exited FlexShares STOXX Global ESG Select Index Fund in Q4 2024, selling an estimated $9.17M.
  • Forefront Analytics's ten largest holdings make up 53% of its $215M portfolio in Q4 2024.
  • Forefront Analytics opened 4 new positions and closed 7 in Q4 2024.
  • Forefront Analytics's portfolio value rose 1.4% quarter-over-quarter to $215M.

Based on Forefront Analytics's 13F filing for Q4 2024, filed 14 Feb 2025.